Navigation Links
ONR funds study of nanoscale wetting dynamics of superhydrophobic surfaces at Stevens
Date:8/30/2011

With a fleet of ships and aircraft that work as hard as the sailors, pilots, and crew that operate them, the US Navy spends approximately $10-12 billion every year to fight corrosion on the hulls and bodies of these important vehicles. To support Office of Naval Research (ONR) development of hydrodynamically efficient and environmentally non-toxic anti-corrosion materials, Dr. Chang-Hwan Choi, Assistant Professor of Mechanical Engineering at Stevens Institute of Technology, researches nanotechnology with multifunctional superhydrophobic properties that repel water and prevent corrosion in robust and durable ways. Dr. Choi's work has recently been awarded a Defense University Research Instrumentation Program (DURIP) grant that backs this work.

"This award recognizes Stevens contributions to the world of multi-scale engineering in support of government defense initiatives. We are proud and honored to see the ever-growing number of faculty distinctions within the University," says Dr. Constantin Chassapis, Department Director of Mechanical Engineering and Deputy Dean for the School of Engineering and Science.

Dr. Choi's 2011 DURIP grant funds an environmental scanning electron microscope (ESEM) that will enhance his study of the functionalities of novel prototypes of nanostructured materials. The ESEM will allow his lab to study and observe the wetting dynamics of waterphenomena such as condensation and evaporationon nano-patterned superhydrophobic surfaces.

ONR has already made long-term investments in Dr. Choi's superhydrophic surface research, including naming him to the prestigious Young Investigator Program. In 2010, he also received a DURIP grant to fund a state-of-the-art thin film deposition system. This instrumentation allows Dr. Choi to deposit layers of light metals such as aluminum, which is commonly used in naval applications, with engineered nanocharacteristics that create a water-repelling surface.

The capability of in-situ measurement of wetting dynamics via the ESEM will support many new experiment opportunities for faculty and students throughout Stevens and enable collaborations with industry and other universities for a variety of research topics in engineering, physics, chemistry, and biology. In addition to research benefits, this instrumentation grant will also support educational initiatives through a new cross-disciplinary PhD concentration in Nanotechnology and the Nanotechnology Graduate Program.

As Director of the Nano and Microfluidics Laboratory at Stevens, Dr. Choi oversees international research collaborations to develop novel nanoscale materials with useful properties for a variety of applications in manufacturing, energy, and defense. Research projects in the lab are currently supported by the National Science Foundation, US Department of Energy, US Army, US Navy, and DARPA.


'/>"/>
Contact: Christine del Rosario
cdelrosa@stevens.edu
Stevens Institute of Technology
Source:Eurekalert

Related biology technology :

1. Society of Interventional Radiology Foundation Funds Howard Hughes Medical Institute Award
2. Maryland Stem Cell Research Commission Funds 36 New Projects in FY 2011
3. FireFly® Toothbrush Facebook Campaign Raises Funds for Smile Train
4. Tech Coast Angels Funds 31 Deals in 2010 and Highlights Three Profitable Exits
5. Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors
6. Alzheimers Drug Discovery Foundation Funds ALS Biopharma to Develop Small Molecules for Alzheimers Disease
7. Department of Energy Funds SRI to Enhance Bioinformatics Tools for Renewable Energy Research
8. NASA funds development of nanoscale materials for high energy density lithium-ion batteries
9. NSF funds infection-resistant orthopedic research
10. Indiana Collaborative Receives $10.3 Million in Federal Stimulus Funds to Improve Healthcare through Information Technology
11. Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):